4.6 Article

The Utility of (1→3)-β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

Jonathan Tschopp et al.

Summary: Immunoglobulins and therapeutic antibody preparations are linked to a high rate of false-positive BDG tests in hematological patients. The benefits of BDG monitoring need to be balanced against the risk of unnecessary investigations and costs resulting from false-positive tests in this population.

CLINICAL INFECTIOUS DISEASES (2022)

Review Microbiology

Challenges with Utilizing the 1,3-Beta-D-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children

Alice J. Hsu et al.

Summary: Establishing the diagnosis of invasive mold infections in immunocompromised children is challenging, with 1,3-beta-D-glucan showing limited accuracy in this population. However, serum and bronchoalveolar lavage galactomannan can be used as diagnostic tools with comparable performance to adults.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Infectious Diseases

Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis

Tirdad T. Zangeneh et al.

MEDICAL MYCOLOGY (2015)

Article Microbiology

Serum (1→3)-β-D-Glucan Measurement in Coccidioidomycosis

George R. Thompson et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2012)

Review Immunology

Coccidioidomycosis in solid organ transplantation

JE Blair et al.

CLINICAL INFECTIOUS DISEASES (2001)